BioCentury | Oct 29, 2012
Company News

Qiagen, Bio*One Capital Pte. Ltd. sales and marketing update

...Dx Assays Pte. Ltd., a JV between Qiagen and Bio*One Capital, launched its fee-for-service companion diagnostic partnership...
...and assay validation services as well as assistance in manufacturing and the regulatory approval process. Bio*One Capital...
...reached for details (see BioCentury, Dec. 10, 2007). Qiagen N.V. (Xetra:QIA; NASDAQ:QGEN), Venlo, the Netherlands Bio*One Capital...
BioCentury | Feb 14, 2011
Politics, Policy & Law

BIO's compendium of ideas

...proposes emulating economic development policies that have been enacted in other countries, such as Singapore's Bio*One Capital...
...it is too controversial, politically difficult or too hard," Greenwood said. Companies and Institutions Mentioned Bio*One Capital...
BioCentury | Jul 19, 2010
Financial News

MerLion completes venture financing

...completed: 7/13/10 Type: Venture financing Raised: $7 million Investors: Aravis Venture; Aurelia Private Equity GmbH; Bio*One Capital...
BioCentury | Jun 14, 2010
Financial News

Inotek completes venture financing

...financing Raised: $18 million Investors: Devon Park Bioventures; Rho Ventures; Care Capital; Pitango; MedImmune Ventures; Bio*One Capital WIR...
BioCentury | Dec 14, 2009
Finance

Ebb & Flow

...Inc. (NASDAQ:CBST); and the Experimental Therapeutics Centre of Singapore. Existing investors Novartis Option Fund and Bio*One Capital...
BioCentury | Dec 7, 2009
Financial News

Forma completes venture financing

...Date completed: 12/1/09 Type: Venture financing Raised: $25.5 million Investors: Lilly Ventures; Novartis Option Fund; Bio*One Capital...
BioCentury | Dec 2, 2009
Financial News

Forma raises $25.5 million

...series B round led by new investor Lilly Ventures. Existing investors Novartis Option Fund and Bio*One Capital...
BioCentury | Oct 12, 2009
Financial News

Inviragen completes venture financing

...completed: 10/6/09 Type: Venture financing Raised: $15 million Investors: Charter Life Sciences; Venture Investors LLC; Bio*One Capital...
BioCentury | Jan 26, 2009
Emerging Company Profile

Corporate Profile

...Novartis AG Number of employees: 45 Funds raised: Not disclosed Investors: Novartis Option Fund and Bio*One Capital...
BioCentury | Oct 21, 2008
Financial News

S*BIO raises $26 million

...S*BIO (Singapore) raised US$26 million in a series B round co-led by existing investor Bio*One Capital and...
Items per page:
1 - 10 of 23
BioCentury | Oct 29, 2012
Company News

Qiagen, Bio*One Capital Pte. Ltd. sales and marketing update

...Dx Assays Pte. Ltd., a JV between Qiagen and Bio*One Capital, launched its fee-for-service companion diagnostic partnership...
...and assay validation services as well as assistance in manufacturing and the regulatory approval process. Bio*One Capital...
...reached for details (see BioCentury, Dec. 10, 2007). Qiagen N.V. (Xetra:QIA; NASDAQ:QGEN), Venlo, the Netherlands Bio*One Capital...
BioCentury | Feb 14, 2011
Politics, Policy & Law

BIO's compendium of ideas

...proposes emulating economic development policies that have been enacted in other countries, such as Singapore's Bio*One Capital...
...it is too controversial, politically difficult or too hard," Greenwood said. Companies and Institutions Mentioned Bio*One Capital...
BioCentury | Jul 19, 2010
Financial News

MerLion completes venture financing

...completed: 7/13/10 Type: Venture financing Raised: $7 million Investors: Aravis Venture; Aurelia Private Equity GmbH; Bio*One Capital...
BioCentury | Jun 14, 2010
Financial News

Inotek completes venture financing

...financing Raised: $18 million Investors: Devon Park Bioventures; Rho Ventures; Care Capital; Pitango; MedImmune Ventures; Bio*One Capital WIR...
BioCentury | Dec 14, 2009
Finance

Ebb & Flow

...Inc. (NASDAQ:CBST); and the Experimental Therapeutics Centre of Singapore. Existing investors Novartis Option Fund and Bio*One Capital...
BioCentury | Dec 7, 2009
Financial News

Forma completes venture financing

...Date completed: 12/1/09 Type: Venture financing Raised: $25.5 million Investors: Lilly Ventures; Novartis Option Fund; Bio*One Capital...
BioCentury | Dec 2, 2009
Financial News

Forma raises $25.5 million

...series B round led by new investor Lilly Ventures. Existing investors Novartis Option Fund and Bio*One Capital...
BioCentury | Oct 12, 2009
Financial News

Inviragen completes venture financing

...completed: 10/6/09 Type: Venture financing Raised: $15 million Investors: Charter Life Sciences; Venture Investors LLC; Bio*One Capital...
BioCentury | Jan 26, 2009
Emerging Company Profile

Corporate Profile

...Novartis AG Number of employees: 45 Funds raised: Not disclosed Investors: Novartis Option Fund and Bio*One Capital...
BioCentury | Oct 21, 2008
Financial News

S*BIO raises $26 million

...S*BIO (Singapore) raised US$26 million in a series B round co-led by existing investor Bio*One Capital and...
Items per page:
1 - 10 of 23